Cargando…

Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study

OBJECTIVE: The purpose of this multicenter retrospective study was to investigate the impact of the prognostic nutritional index (PNI) on the survival of Japanese patients with hepatocellular carcinoma (HCC) treated with sorafenib. METHODS: A total of 178 HCC patients from May 2009 to December 2015...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatanaka, Takeshi, Kakizaki, Satoru, Uehara, Daisuke, Nagashima, Tamon, Ueno, Takashi, Namikawa, Masashi, Saito, Shuichi, Hosonuma, Kenichi, Suzuki, Hideyuki, Naganuma, Atsushi, Takagi, Hitoshi, Sato, Ken, Uraoka, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663544/ https://www.ncbi.nlm.nih.gov/pubmed/30918170 http://dx.doi.org/10.2169/internalmedicine.1594-18

Ejemplares similares

Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately
por: Tojima, Hiroki, et al.
Publicado: (2021)

Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment
por: Hatanaka, Takeshi, et al.
Publicado: (2020)

Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct‐acting antivirals
por: Takakusagi, Satoshi, et al.
Publicado: (2021)

Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Adenosquamous Carcinoma of the Choledochus
por: Uehara, Daisuke, et al.
Publicado: (2019)

Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases
por: Sato, Ken, et al.
Publicado: (2023)

Incidence, Mortality, and Predictive Factors of Hepatocellular Carcinoma in Primary Biliary Cirrhosis
por: Hosonuma, Kenichi, et al.
Publicado: (2013)

Lenvatinib for Hepatocellular Carcinoma: A Literature Review
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct‐acting antivirals
por: Takakusagi, Satoshi, et al.
Publicado: (2020)

Intratumoral Hemorrhage of Liver Metastasis from a Rectal Neuroendocrine Tumor
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure
por: Hatanaka, Takeshi, et al.
Publicado: (2019)

Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?
por: Hatanaka, Takeshi, et al.
Publicado: (2022)

Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
por: Hatanaka, Takeshi, et al.
Publicado: (2023)

Impact of Pemafibrate in Patients with Hypertriglyceridemia and Metabolic Dysfunction-associated Fatty Liver Disease Pathologically Diagnosed with Non-alcoholic Steatohepatitis: A Retrospective, Single-arm Study
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology
por: Uehara, Daisuke, et al.
Publicado: (2018)

The first reported case of Noonan syndrome complicated with hepatocellular carcinoma
por: Kakizaki, Satoru, et al.
Publicado: (2021)

Successfully Treated Case of Cholangiolocellular Carcinoma with a Poor Hepatic Functional Reserve Reporting with Various Imaging Findings
por: Takakusagi, Satoshi, et al.
Publicado: (2020)

Impact of M2BPGi on the Hepatocarcinogenesis after the Combination Therapy with Daclatasvir and Asunaprevir for Hepatitis C
por: Takakusagi, Satoshi, et al.
Publicado: (2021)

Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy
por: Sato, Ken, et al.
Publicado: (2022)

Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab
por: Uehara, Sanae, et al.
Publicado: (2023)

A Resected Case of Follicular Cholangitis That Was Positive on (18)F-fluorodeoxyglucose-positron Emission Tomography
por: Kosone, Takashi, et al.
Publicado: (2020)

A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab
por: Saito, Naoto, et al.
Publicado: (2022)

Relationship between Being Overweight and Clinical Outcomes of Ablation Therapy for Hepatocellular Carcinoma under Ultrasound Guidance: A Retrospective Analysis
por: Hatanaka, Takeshi, et al.
Publicado: (2023)

The Diagnosis, Pathophysiology, and Treatment of Chronic Hepatitis E Virus Infection—A Condition Affecting Immunocompromised Patients
por: Takakusagi, Satoshi, et al.
Publicado: (2023)

Partial liver irradiation in rats induces the hypertrophy of nonirradiated liver lobes through hepatocyte proliferation(†)
por: Adachi, Takuya, et al.
Publicado: (2023)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Prolonged SARS‐CoV‐2 infection during obinutuzumab and bendamustine treatment for follicular lymphoma: A case report
por: Kambe, Ryosuke, et al.
Publicado: (2023)

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality
por: Hiraoka, Atsushi, et al.
Publicado: (2023)

Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
por: Yamada, Hodaka, et al.
Publicado: (2022)

An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice
por: Yamazaki, Yuichi, et al.
Publicado: (2021)

Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
por: Yamada, Hodaka, et al.
Publicado: (2023)

Integrative roles of transforming growth factor-α in the cytoprotection mechanisms of gastric mucosal injury
por: Kosone, Takashi, et al.
Publicado: (2006)

Endoscopic and video capsule endoscopic observation of Yersinia enterocolitis
por: Marubashi, Kyouko, et al.
Publicado: (2023)

Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
por: Sato, Ken, et al.
Publicado: (2019)

Colorectal gel immersion endoscopic submucosal dissection using the tunneling method
por: Nakano, Yuya, et al.
Publicado: (2023)

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma
por: Okusaka, Takuji, et al.
Publicado: (2023)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Submucosal injection solution for gastrointestinal tract endoscopic mucosal resection and endoscopic submucosal dissection
por: Uraoka, Toshio, et al.
Publicado: (2009)

Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
por: Sanda, Mariko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_92cs1roe7r8la06je2jflk0v5e